Kerri Ann Bostrom

Title: Kerri Ann Bostrom: Innovator in Antigen-Binding Proteins

Introduction

Kerri Ann Bostrom is a notable inventor based in Minneapolis, MN (US). She has made significant contributions to the field of biotechnology, particularly in the development of binding proteins that target human CD30.

Latest Patents

Kerri Ann Bostrom holds one patent titled "Human CD30-specific binding proteins and uses thereof." This patent relates to antigen-binding affinity reagents for an analyte-of-interest. The disclosure provides novel binding proteins, including derivatives and fragments, that specifically target human CD30.

Career Highlights

Bostrom is currently employed at R & D Systems, Inc., where she continues to advance her research in the field of antigen-binding proteins. Her work has implications for various applications in medical diagnostics and therapeutics.

Collaborations

Throughout her career, Kerri has collaborated with esteemed colleagues, including Cyrus B Munshi and Julie Anne Werner. These collaborations have further enriched her research and contributed to the advancement of her projects.

Conclusion

Kerri Ann Bostrom is a pioneering inventor whose work in antigen-binding proteins has the potential to impact the field of biotechnology significantly. Her contributions continue to inspire innovation in medical research and applications.